29th September - 2nd October 2020 (GMT+01:00) Europe/London
This event is going virtual!
View the virtual event programme
If you are having issues registering for the event please create or login to your MyBIR account via this link and then register for the event after you have logged in. If you are still experiencing any issues please email email@example.com
Advanced Accelerator Applications, S.A. (AAA), a Novartis company, is an innovative medicines company developing targeted radioligand therapies and precision imaging radioligands for oncology. We are committed to transforming patients’ lives by leading innovation in nuclear medicine. AAA currently has over 1,000 employees working across 31 sites in 12 countries (Canada, France, Germany, Israel, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, the UK and the US). The company also has global manufacturing capabilities with 19 facilities in eight countries, and six research & development sites. For more information, please visit: https://www.adacap.com/.
GE Healthcare is a leading global medical technology and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform. With over 100 years of healthcare industry experience and around 50,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world. Follow us on Facebook, LinkedIn, Twitter and Insights , or visit our website www.gehealthcare.com for more information.
Hermes Medical Solutions provides a comprehensive range of vendor-neutral software solutions for radionuclide therapy and dosimetry to help you personalise treatment for your patients, including Voxel Dosimetry with Monte Carlo dose simulation and theranostics dose prediction, organ dosimetry including OLINDA/EXM, and SUV-SPECT® quantitative SPECT reconstruction for any radionuclide and camera.
MIM Software offers a suite of applications that support Radiology and Nuclear Medicine’s important role in the patient care pathway. MIM products emphasize the importance of quantitation, collaboration, and data management. MIM SurePlan™ MRT provides voxel-based dosimetry for Molecular Radiotherapy, deformable registration, and timesaving tools for organ and tumor segmentation.
Sirtex Medical is a global healthcare business with offices in the U.S., Australia, Germany and Singapore, working to improve outcomes in people with cancer. Our lead product is a targeted radiation therapy for liver cancer called SIR-Spheres® Y-90 resin microspheres. More than 100,000 doses have been supplied to treat patients with liver cancer at more than 1,300 medical centers in over 50 countries.
Terumo Interventional Systems is working in partnership with Interventional Radiologists and Nuclear Medics within Interventional Oncology to ensure they have access to high quality tools for their patients. QuiremSpheres®microspheres, QuiremScout® microspheres and Q-SuiteTM software make up The Holmium Platform: three integrated products which aims to individualize SIRT at its full potential.l QuiremSpheres® is the first Holmium-166 microsphere on the market which brings a wide range of benefits from higher dose rate, to optimized imaging capabilities.